Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis

Trial Profile

Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis

Completed
Phase of Trial: Phase 0

Latest Information Update: 24 Aug 2017

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Optic neuritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2017 Status changed from recruiting to completed.
    • 22 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
    • 25 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top